The adverse effects of brand-name drug prescribing

被引：7

|

作者：

Flegel, Ken

机构：

来源：

CANADIAN MEDICAL ASSOCIATION JOURNAL | 2012年 / 184卷 / 05期

关键词：

D O I：

10.1503/cmaj.112160

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：616 / 616

页数：1

相关论文

共 50 条

[41] Brand-name drug companies fail to meet R&D commitments
Kondro, Wayne
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 175 (04) : 344 - 344
[42] The Comparison of Brand-Name and Generic Formulations of Venlafaxine: A Therapeutic Drug Monitoring Analysis
Unterecker, Stefan
Proft, Florian
Riederer, Peter
Lauer, Martin
Deckert, Juergen
Pfuhlmann, Bruno
THERAPEUTIC DRUG MONITORING, 2014, 36 (02) : 269 - 272
[43] Pharmacy Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing
Bai, Ge
Sen, Aditi P.
Anderson, Gerard F.
ANNALS OF INTERNAL MEDICINE, 2018, 168 (06) : 436 - +
[44] HOW TO GET BRAND-NAME, OPTIMUM MUSEUMS
ESTEROW, M
ARTNEWS, 1990, 89 (05): : 238 - 238
[45] Equivalence of generic and brand-name ophthalmic products
Fiscella, RG
Gaynes, BI
Jensen, M
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (07) : 616 - 617
[46] Brand Loyalty and Generic Entry: Why Do Brand-Name Drug Companies Launch Their Own Generics?
Yunyun Wan
The Japanese Economic Review, 2018, 69 : 340 - 346
[47] COLEMAN - GROWING TO MATCH ITS BRAND-NAME
LABATE, J
FORTUNE, 1994, 129 (12) : 114 - 114
[48] HERE COME BRAND-NAME FRUIT AND VEGGIES
TRACY, EJ
FORTUNE, 1985, 111 (04) : 105 - 105
[49] Brand Loyalty and Generic Entry: Why do Brand-Name Drug Companies Launch Their Own Generics?
Wan, Yunyun
JAPANESE ECONOMIC REVIEW, 2018, 69 (03) : 340 - 346
[50] The Value of Specifying Brand-name Antiepileptic Drugs
Ng, Yu-tze
ARCHIVES OF NEUROLOGY, 2009, 66 (11) : 1415 - 1416

← 1 2 3 4 5 →